Risk Analysis Expert To Deliver Basics Of Risk Know-How
Catherine St. Hilaire, Ph. D., will discuss the how’s and why’s of risk analysis and risk management at the June 22, 2006, meeting of the Regulatory Affairs Professional Society (RAPS) (http://www. raps. org/s_raps/index. asp). The meeting is being held at the campus of the Federation of American Societies for Experimental Biology (FASEB) beginning at 6:00 PM. The media are invited to attend.
Bethesda, MD (PRWEB) June 13, 2006 —
Risk analysis and management have become buzzwords—blanket terms used to describe the reengineering of government agencies responsible for public health and safety. But, as companies who must comply with new agency initiatives have learned, the devil is in the details. How should risks be identified? Are all risks alike? Can risk be reduced to simply a number? What are the best risk management options to mitigate particular risks?
Effective risk analysis and management in general — and as they relate to the Food And Drug Administration’s (FDA) latest effort to enhance good manufacturing practices (GMPs) in particular — are key if a company is to succeed. To help organizations establish risk management procedures, Catherine St. Hilaire, Ph. D., will discuss the how’s and why’s of risk analysis and risk management at the June 22, 2006, meeting of the Regulatory Affairs Professional Society (RAPS) (http://www. raps. org/s_raps/index. asp (http://www. raps. org/s_raps/index. asp)). The meeting is being held at the campus of the Federation of American Societies for Experimental Biology (FASEB) beginning at 6:00 PM. The media are invited to attend.
Dr. St. Hilaire is a Senior Scientist with the Center for Health Risk Analysis (CHRA) (http://www. lsro. org/risk_analysis. html (http://www. lsro. org/risk_analysis. html)), one of the expert scientific services offered by the Life Sciences Research Office (LSRO). She is a former executive with Hershey Foods, Inc., and ENVIRON, Inc. Dr. St. Hilaire will draw upon her experience as a risk analyst in the private sector to provide a road map for developing effective risk management programs in consumer product companies.
In an era characterized by public concern over risks and heightened scrutiny of business practices, the topic is a timely one.
For more information about Dr. St. Hilaire’s presentation, or to register to attend, please contact RAPS at 301.770.2920, ext. 200.
*** The event is being held at the offices of the Life Sciences Research Office (LSRO), located on the FASEB campus, 9650 Rockville Pike, Rockville, MD. For directions, log on to: http://www. lsro. org/about/directions. html (http://www. lsro. org/about/directions. html). Media are welcome to attend.
About LSRO
For more than 40 years, the Life Sciences Research Office, Inc. (LSRO) has provided expert scientific evaluation, advice and services to the government and private sectors. Highly regarded for its distinctive approach, the suburban Washington, DC-based LSRO taps the knowledge of the scientific community to direct global leaders to intelligent, science-based decisions. LSRO offers a flexible portfolio of services and publications that are timely, accurate and unbiased. To learn more, visit HTTP://WWW. LSRO. ORG/.
About RAPS
The Regulatory Affairs Professionals Society (RAPS) is the leading worldwide member organization devoted to the health product regulatory profession. With more than 10,000 individual members from industry, government, research, clinical and academic organizations in more than 50 countries, RAPS develops professional standards for knowledge, competency and ethics and is the leading source of information on the scope of practice of regulatory professionals and their critical roles in the health sector. Visit their website at www. raps. org.
For more information about Dr. St. Hilaire’s risk management presentation, please contact Donna Krupa at 703.527.7357.
# # #
